home · filing · 0001104659-24-000121
8-K filed January 2, 2024, 6:59 PM ET
ticker IMNM
CIK 0001472012
leadership
confidence high
sentiment neutral
materiality 0.25
Immunome appoints Carol Schafer as director, Audit Committee Chair
Immunome Inc.
Carol Schafer appointed Class I director, Chair of Audit Committee, and member of Nominating Committee, effective Jan 2, 2024.
Annual retainers: $40,000 for board, $15,000 for Audit Chair, $5,000 for Nominating Committee; plus option grant worth $270,000.
James Boylan and Jean-Jacques Bienaimé stepped down from Audit and Nominating Committees, respectively.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Carol Schafer
Class I Director
Effective 2024-01-02
Filed January 2, 2024, 6:59 PM ET
appointed Carol Schafer as a Class I director of the Company
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Carol Schafer was appointed as Class I Director at Immunome Inc..
Action appointed
Role Class I Director
Exact text from the filing
appointed Carol Schafer as a Class I director of the Company
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-24-000121
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.